2026

Impact of zervimesine on the neuroinflammatory biomarker GFAP and related proteomic molecular correlates in plasma of participants from a phase 2 clinical trial in Alzheimer’s disease.

Di Caro V, Cho E, Thiel J, Lizama BN, Koel-Simmelink MJA, Pandey K, Duong D, Seyfried NT, Grundman M, Teunissen CE, Zetterberg H, Blennow K, Caggiano AO, Hamby ME. Impact of zervimesine on the neuroinflammatory biomarker GFAP and related proteomic molecular correlates in plasma of participants from a phase 2 clinical trial in Alzheimer’s disease. […]

Subtyping based on hippocampal cryptic exon burden reveals proteome-wide changes associated with TDP-43 and Alzheimer’s disease pathology.

Trautwig AN, Shantaraman A, Chung M, Dammer EB, Ping L, Duong DM, Watson CM, Petrucelli L, Ward ME, Glass JD, Nelson PT, Levey AI, McEachin ZT, Seyfried NT. Subtyping based on hippocampal cryptic exon burden reveals proteome-wide changes associated with TDP-43 and Alzheimer’s disease pathology. Cell Rep. 2026 Mar 18;45(4):117142. doi: 10.1016/j.celrep.2026.117142. Epub ahead of […]